Harbor Investment Advisory’s Vanda Pharmaceuticals VNDA Stock Holding History

Harbor Investment Advisory’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,094	Closed	-$15.5K	–	1371
2022 Q4	$15.5K	Hold	2,094	–	–	﹤0.01%	943
2022 Q3	$21K	Hold	2,094	–	–	﹤0.01%	901
2022 Q2	$23K	Sell	2,094 -565	-21%	-$5.85K	﹤0.01%	880
2022 Q1	$30K	Hold	2,659	–	–	﹤0.01%	864
2021 Q4	$42K	Hold	2,659	–	–	0.01%	788
2021 Q3	$46K	Hold	2,659	–	–	0.01%	761
2021 Q2	$57K	Hold	2,659	–	–	0.01%	673
2021 Q1	$40K	Hold	2,659	–	–	0.01%	736
2020 Q4	$35K	Buy	2,659 +797	+43%	+$9.59K	0.01%	721
2020 Q3	$18K	Buy	1,862 +939	+102%	+$10K	﹤0.01%	766
2020 Q2	$11K	Hold	923	–	–	﹤0.01%	773
2020 Q1	$10K	Buy	+923	New	+$11.4K	﹤0.01%	746

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Harbor Investment Advisory's VNDA Position: Q1 2023 in Review

Harbor Investment Advisory sold out of Vanda Pharmaceuticals (VNDA) in Q1 2023, closing a stake of 2,094 shares — an estimated $15.5K sold.

Harbor Investment Advisory first reported a position in VNDA in Q1 2020 and held it in 12 quarters. The position peaked at $57K in Q2 2021. 177 funds tracked by Wall St. Rank hold VNDA as of Q1 2023.

Harbor Investment Advisory reported no remaining Vanda Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Harbor Investment Advisory sold 2,094 Vanda Pharmaceuticals shares in Q1 2023, an estimated $15.5K.
Harbor Investment Advisory first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 12 quarters.
Harbor Investment Advisory's Vanda Pharmaceuticals position peaked at $57K in Q2 2021.
177 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2023.

Based on Harbor Investment Advisory's 13F filing for Q1 2023, filed 21 Apr 2023.